The Paracaspase MALT1

Biochimie

Volumn 122, Issue , 2016, Pages 324-338

  Hachmann, Janna ^a   Salvesen, Guy S ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Caspase; Mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1); NF B signaling; Protease

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; B LYMPHOCYTE RECEPTOR; CARD CONTAINING MEMBRANE ASSOCIATED GUANYLATE KINASE 1; CASPASE; CASPASE RECRUITMENT DOMAIN PROTEIN 2; CASPASE RECRUITMENT DOMAIN PROTEIN 3; CASPASE RECRUITMENT DOMAIN PROTEIN 9; DECTIN 1; DECTION 2; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1; PARACASPASE; PECAZINE; PHENOTHIAZINE DERIVATIVE; PROTEIN; PROTEIN BCL 10; PROTEIN INHIBITOR; PROTEINASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; MALT1 PROTEIN, HUMAN; TUMOR PROTEIN;

B LYMPHOCYTE; BINDING SITE; BONE MARROW CELL; CATALYSIS; CELL MATURATION; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FUNGUS; HUMAN; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; KNOCKOUT MOUSE; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; MARGINAL ZONE LYMPHOMA; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PROTEIN DEGRADATION;

ANIMALS; CASPASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NF-KAPPA B; PROTEOLYSIS; SIGNAL TRANSDUCTION;

EID: 84957810123     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.09.018     Document Type: Review

References (115)

1. M.Q. Du MALT lymphoma: recent advances in aetiology and molecular genetics J. Clin. Exp. Hematopathol. 47 2007 31 42
2. P. Isaacson, and D.H. Wright Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue Cancer 53 1984 2515 2524
3. P.G. Isaacson, and M.Q. Du MALT lymphoma: from morphology to molecules Nat. Rev. Cancer 4 2004 644 653
4. T. Sugiyama, M. Asaka, T. Nakamura, S. Nakamura, S. Yonezumi, and M. Seto API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma Gastroenterology 120 2001 1884 1885
5. E.G. Levine, D.C. Arthur, J. Machnicki, G. Frizzera, D. Hurd, B. Peterson, K.J. Gajl-Peczalska, and C.D. Bloomfield Four new recurring translocations in non-hodgkin lymphoma Blood 74 1989 1796 1800
6. J. Dierlamm, M. Baens, I. Wlodarska, M. Stefanova-Ouzounova, J.M. Hernandez, D.K. Hossfeld, C. De Wolf-Peeters, A. Hagemeijer, H. Van den Berghe, and P. Marynen The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6ssociated with mucosa-associated lymphoid tissue lymphomas Blood 93 1999 3601 3609
7. A.G. Uren, K. O'Rourke, L.A. Aravind, M.T. Pisabarro, S. Seshagiri, E.V. Koonin, and V.M. Dixit Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma Mol. Cell 6 2000 961 967
8. N.D. Rawlings, F.R. Morton, C.Y. Kok, J. Kong, and A.J. Barrett MEROPS: the peptidase database Nucleic Acids Res. 36 2008 D320 D325
9. J.M. Chen, N.D. Rawlings, R.A. Stevens, and A.J. Barrett Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases FEBS Lett. 441 1998 361 365
10. S.J. Snipas, E. Wildfang, T. Nazif, L. Christensen, K.M. Boatright, M. Bogyo, H.R. Stennicke, and G.S. Salvesen Characteristics of the caspase-like catalytic domain of human paracaspase Biol. Chem. 385 2004 1093 1098
11. B. Coornaert, M. Baens, K. Heyninck, T. Bekaert, M. Haegman, J. Staal, L. Sun, Z.J. Chen, P. Marynen, and R. Beyaert T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20 Nat. Immunol. 9 2008 263 271
12. F. Rebeaud, S. Hailfinger, A. Posevitz-Fejfar, M. Tapernoux, R. Moser, D. Rueda, O. Gaide, M. Guzzardi, E.M. Iancu, N. Rufer, N. Fasel, and M. Thome The proteolytic activity of the paracaspase MALT1 is key in T cell activation Nat. Immunol. 9 2008 272 281
13. C. Wiesmann, L. Leder, J. Blank, A. Bernardi, S. Melkko, A. Decock, A. D'Arcy, F. Villard, P. Erbel, N. Hughes, F. Freuler, R. Nikolay, J. Alves, F. Bornancin, and M. Renatus Structural determinants of MALT1 protease activity J. Mol. Biol. 419 2012 4 21
14. J.W. Yu, P.D. Jeffrey, J.Y. Ha, X. Yang, and Y. Shi Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region Proc. Natl. Acad. Sci. U. S. A. 108 2011 21004 21009
15. J. Hachmann, S.J. Snipas, B.J. van Raam, E.M. Cancino, E.J. Houlihan, M. Poreba, P. Kasperkiewicz, M. Drag, and G.S. Salvesen Mechanism and specificity of the human paracaspase MALT1 Biochem. J. 443 2012 287 295
16. L. Qiu, and S. Dhe-Paganon Oligomeric structure of the MALT1 tandem Ig-Like domains PLoS One 6 2011 e23220
17. P. Fuentes-Prior, and G.S. Salvesen The protein structures that shape caspase activity, specificity, activation and inhibition Biochem. J. 384 2004 201 232
18. I. Schechter, and M. Berger On the size of the active site in proteases Biochem. Biophys. Res. Commun. 27 1967 157 162
19. H.R. Stennicke, M. Renatus, M. Meldal, and G.S. Salvesen Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8 Biochem. J. 350 2000 563 568
20. M.S. Hayden, and S. Ghosh NF-kappaB, the first quarter-century: remarkable progress and outstanding questions Genes Dev. 26 2012 203 234
21. A. Oeckinghaus, M.S. Hayden, and S. Ghosh Crosstalk in NF-kappaB signaling pathways Nat. Immunol. 12 2011 695 708
22. S.C. Sun Non-canonical NF-kappaB signaling pathway Cell Res. 21 2011 71 85
23. R. Matsumoto, D. Wang, M. Blonska, H. Li, M. Kobayashi, B. Pappu, Y. Chen, D. Wang, and X. Lin Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation Immunity 23 2005 575 585
24. J. Bertin, L. Wang, Y. Guo, M.D. Jacobson, J.L. Poyet, S.M. Srinivasula, S. Merriam, P.S. DiStefano, and E.S. Alnemri CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B J. Biol. Chem. 276 2001 11877 11882
25. J. Ruland, G.S. Duncan, A. Elia, I. del Barco Barrantes, L. Nguyen, S. Plyte, D.G. Millar, D. Bouchard, A. Wakeham, P.S. Ohashi, and T.W. Mak Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure Cell 104 2001 33 42
26. H. Hara, T. Wada, C. Bakal, I. Kozieradzki, S. Suzuki, N. Suzuki, M. Nghiem, E.K. Griffiths, C. Krawczyk, B. Bauer, F. D'Acquisto, S. Ghosh, W.C. Yeh, G. Baier, R. Rottapel, and J.M. Penninger The MAGUK family protein CARD11 is essential for lymphocyte activation Immunity 18 2003 763 775
27. T. Egawa, B. Albrecht, B. Favier, M.J. Sunshine, K. Mirchandani, W. O'Brien, M. Thome, and D.R. Littman Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation Curr. Biol. 13 2003 1252 1258
28. D. Wang, Y. You, S.M. Case, L.M. McAllister-Lucas, L. Wang, P.S. DiStefano, G. Nunez, J. Bertin, and X. Lin A requirement for CARMA1 in TCR-induced NF-kappa B activation Nat. Immunol. 3 2002 830 835
29. O. Gaide, B. Favier, D.F. Legler, D. Bonnet, B. Brissoni, S. Valitutti, C. Bron, J. Tschopp, and M. Thome CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation Nat. Immunol. 3 2002 836 843
30. A.A. Ruefli-Brasse, D.M. French, and V.M. Dixit Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase Science 302 2003 1581 1584
31. J. Ruland, G.S. Duncan, A. Wakeham, and T.W. Mak Differential requirement for Malt1 in T and B cell antigen receptor signaling Immunity 19 2003 749 758
32. J.E. Jun, L.E. Wilson, C.G. Vinuesa, S. Lesage, M. Blery, L.A. Miosge, M.C. Cook, E.M. Kucharska, H. Hara, J.M. Penninger, H. Domashenz, N.A. Hong, R.J. Glynne, K.A. Nelms, and C.C. Goodnow Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis Immunity 18 2003 751 762
33. K. Newton, and V.M. Dixit Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes Curr. Biol. 13 2003 1247 1251
34. T. Pohl, R. Gugasyan, R.J. Grumont, A. Strasser, D. Metcalf, D. Tarlinton, W. Sha, D. Baltimore, and S. Gerondakis The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 4514 4519
35. F. Martin, and J.F. Kearney B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory" Immunol. Rev. 175 2000 70 79
36. F. Martin, A.M. Oliver, and J.F. Kearney Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens Immunity 14 2001 617 629
37. A. Tarakhovsky Bar Mitzvah for B-1 cells: how will they grow up? J. Exp. Med. 185 1997 981 984
38. R.N. Germain T-cell development and the CD4-CD8 lineage decision Nat. Rev. Immunol. 2 2002 309 322
39. H. von Boehmer Unique features of the pre-T-cell receptor alpha-chain: not just a surrogate Nat. Rev. Immunol. 5 2005 571 577
40. L.M. Kingeter, and B.C. Schaefer Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset J. Immunol. 181 2008 6244 6254
41. U. Ferch, C.M. zum Buschenfelde, A. Gewies, E. Wegener, S. Rauser, C. Peschel, D. Krappmann, and J. Ruland MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit Nat. Immunol. 8 2007 984 991
42. A. Brüstle, D. Brenner, C.B. Knobbe, P.A. Lang, C. Virtanen, B.M. Hershenfield, C. Reardon, S.M. Lacher, J. Ruland, P.S. Ohashi, and T.W. Mak The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells J. Clin. Invest. 122 2012 4698 4709
43. C. Mc Guire, P. Wieghofer, L. Elton, D. Muylaert, M. Prinz, R. Beyaert, and G. van Loo Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination J. Immunol. 190 2013 2896 2903
44. L.M. McAllister-Lucas, J. Ruland, K. Siu, X. Jin, S. Gu, D.S. Kim, P. Kuffa, D. Kohrt, T.W. Mak, G. Nunez, and P.C. Lucas CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells Proc. Natl. Acad. Sci. U. S. A. 104 2007 139 144
45. J. Bertin, Y. Guo, L. Wang, S.M. Srinivasula, M.D. Jacobson, J.L. Poyet, S. Merriam, M.Q. Du, M.J. Dyer, K.E. Robison, P.S. DiStefano, and E.S. Alnemri CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B J. Biol. Chem. 275 2000 41082 41086
46. L.M. McAllister-Lucas, N. Inohara, P.C. Lucas, J. Ruland, A. Benito, Q. Li, S. Chen, F.F. Chen, S. Yamaoka, I.M. Verma, T.W. Mak, and G. Nunez Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction J. Biol. Chem. 276 2001 30589 30597
47. B.C. Grabiner, M. Blonska, P.C. Lin, Y. You, D. Wang, J. Sun, B.G. Darnay, C. Dong, and X. Lin CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation Genes Dev. 21 2007 984 996
48. M. Blonska, and X. Lin NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins Cell Res. 21 2011 55 70
49. M.W. Tusche, L.A. Ward, F. Vu, D. McCarthy, M. Quintela-Fandino, J. Ruland, J.L. Gommerman, and T.W. Mak Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets J. Exp. Med. 206 2009 2671 2683
50. W. Dong, Y. Liu, J. Peng, L. Chen, T. Zou, H. Xiao, Z. Liu, W. Li, Y. Bu, and Y. Qi The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4 J. Biol. Chem. 281 2006 26029 26040
51. H. Hara, C. Ishihara, A. Takeuchi, T. Imanishi, L. Xue, S.W. Morris, M. Inui, T. Takai, A. Shibuya, S. Saijo, Y. Iwakura, N. Ohno, H. Koseki, H. Yoshida, J.M. Penninger, and T. Saito The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors Nat. Immunol. 8 2007 619 629
52. O. Gross, A. Gewies, K. Finger, M. Schafer, T. Sparwasser, C. Peschel, I. Forster, and J. Ruland Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity Nature 442 2006 651 656
53. E.O. Glocker, A. Hennigs, M. Nabavi, A.A. Schaffer, C. Woellner, U. Salzer, D. Pfeifer, H. Veelken, K. Warnatz, F. Tahami, S. Jamal, A. Manguiat, N. Rezaei, A.A. Amirzargar, A. Plebani, N. Hannesschlager, O. Gross, J. Ruland, and B. Grimbacher A homozygous CARD9 mutation in a family with susceptibility to fungal infections N. Engl. J. Med. 361 2009 1727 1735
54. S.I. Gringhuis, B.A. Wevers, T.M. Kaptein, T.M. van Capel, B. Theelen, T. Boekhout, E.C. de Jong, and T.B. Geijtenbeek Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2 PLoS Pathog. 7 2011 e1001259
55. J. Louten, K. Boniface, and R. de Waal Malefyt Development and function of TH17 cells in health and disease J. Allergy Clin. Immunol. 123 2009 1004 1011
56. Y. Chen, B.P. Pappu, H. Zeng, L. Xue, S.W. Morris, X. Lin, R. Wen, and D. Wang B cell lymphoma 10 is essential for FcepsilonR-mediated degranulation and IL-6 production in mast cells J. Immunol. 178 2007 49 57
57. S. Klemm, J. Gutermuth, L. Hultner, T. Sparwasser, H. Behrendt, C. Peschel, T.W. Mak, T. Jakob, and J. Ruland The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation J. Exp. Med. 203 2006 337 347
58. J.A. Hamerman, M. Ni, J.R. Killebrew, C.L. Chu, and C.A. Lowell The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells Immunol. Rev. 232 2009 42 58
59. S.N. Abraham, and A.L. St John Mast cell-orchestrated immunity to pathogens Nat. Rev. Immunol. 10 2010 440 452
60. O. Gross, C. Grupp, C. Steinberg, S. Zimmermann, D. Strasser, N. Hannesschlager, W. Reindl, H. Jonsson, H. Huo, D.R. Littman, C. Peschel, W.M. Yokoyama, A. Krug, and J. Ruland Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production Blood 112 2008 2421 2428
61. V. Katritch, V. Cherezov, and R.C. Stevens Structure-function of the G protein-coupled receptor superfamily Annu. Rev. Pharmacol. Toxicol. 53 2013 531 556
62. B.K. Kobilka G protein coupled receptor structure and activation Biochim. Biophys. Acta 1768 2007 794 807
63. R. Cummings, Y. Zhao, D. Jacoby, E.W. Spannhake, M. Ohba, J.G. Garcia, T. Watkins, D. He, B. Saatian, and V. Natarajan Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells J. Biol. Chem. 279 2004 41085 41094
64. S. Klemm, S. Zimmermann, C. Peschel, T.W. Mak, and J. Ruland Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production Proc. Natl. Acad. Sci. U. S. A. 104 2007 134 138
65. D. Wang, Y. You, P.C. Lin, L. Xue, S.W. Morris, H. Zeng, R. Wen, and X. Lin Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors Proc. Natl. Acad. Sci. U. S. A. 104 2007 145 150
66. A. Benigni, P. Cassis, and G. Remuzzi Angiotensin II revisited: new roles in inflammation, immunology and aging EMBO Mol. Med. 2 2010 247 257
67. M.I. Phillips, and S. Kagiyama Angiotensin II as a pro-inflammatory mediator Curr. Opin. Invest. Drugs 3 2002 569 577
68. P.C. Delekta, I.J. Apel, S. Gu, K. Siu, Y. Hattori, L.M. McAllister-Lucas, and P.C. Lucas Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3.Bcl10.MALT1 signalosome J. Biol. Chem. 285 2010 41432 41442
69. D. Martin, R. Galisteo, and J.S. Gutkind CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex J. Biol. Chem. 284 2009 6038 6042
70. A.O. Rehman, and C.Y. Wang CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex Int. J. Oral Sci. 1 2009 105 118
71. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, and J.W. Vardiman WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 World Health Organization
72. J.R. Anderson, J.O. Armitage, and D.D. Weisenburger Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project Ann. Oncol. 9 1998 717 720
73. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, J.I. Powell, L. Yang, G.E. Marti, T. Moore, J. Hudson Jr., L. Lu, D.B. Lewis, R. Tibshirani, G. Sherlock, W.C. Chan, T.C. Greiner, D.D. Weisenburger, J.O. Armitage, R. Warnke, R. Levy, W. Wilson, M.R. Grever, J.C. Byrd, D. Botstein, P.O. Brown, and L.M. Staudt Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
74. A. Rosenwald, G. Wright, W.C. Chan, J.M. Connors, E. Campo, R.I. Fisher, R.D. Gascoyne, H.K. Muller-Hermelink, E.B. Smeland, J.M. Giltnane, E.M. Hurt, H. Zhao, L. Averett, L. Yang, W.H. Wilson, E.S. Jaffe, R. Simon, R.D. Klausner, J. Powell, P.L. Duffey, D.L. Longo, T.C. Greiner, D.D. Weisenburger, W.G. Sanger, B.J. Dave, J.C. Lynch, J. Vose, J.O. Armitage, E. Montserrat, A. Lopez-Guillermo, T.M. Grogan, T.P. Miller, M. LeBlanc, G. Ott, S. Kvaloy, J. Delabie, H. Holte, P. Krajci, T. Stokke, L.M. Staudt P. Lymphoma/Leukemia Molecular Profiling The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N. Engl. J. Med. 346 2002 1937 1947
75. R.E. Davis, K.D. Brown, U. Siebenlist, and L.M. Staudt Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells J. Exp. Med. 194 2001 1861 1874
76. L.T. Lam, R.E. Davis, J. Pierce, M. Hepperle, Y. Xu, M. Hottelet, Y. Nong, D. Wen, J. Adams, L. Dang, and L.M. Staudt Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling Clin. Cancer. Res. 11 2005 28 40
77. J.L. Cultrera, and S.M. Dalia Diffuse large B-cell lymphoma: current strategies and future directions Cancer Control J. Moffitt Cancer Cent. 19 2012 204 213
78. L.M. Morton, S.S. Wang, S.S. Devesa, P. Hartge, D.D. Weisenburger, and M.S. Linet Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood 107 2006 265 276
79. V.N. Ngo, R.E. Davis, L. Lamy, X. Yu, H. Zhao, G. Lenz, L.T. Lam, S. Dave, L. Yang, J. Powell, and L.M. Staudt A loss-of-function RNA interference screen for molecular targets in cancer Nature 441 2006 106 110
80. U. Ferch, B. Kloo, A. Gewies, V. Pfander, M. Duwel, C. Peschel, D. Krappmann, and J. Ruland Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells J. Exp. Med. 206 2009 2313 2320
81. S. Hailfinger, G. Lenz, V. Ngo, A. Posvitz-Fejfar, F. Rebeaud, M. Guzzardi, E.M. Penas, J. Dierlamm, W.C. Chan, L.M. Staudt, and M. Thome Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma Proc. Natl. Acad. Sci. U. S. A. 106 2009 19946 19951
82. M. Baens, S. Fevery, X. Sagaert, H. Noels, S. Hagens, V. Broeckx, A.D. Billiau, C. De Wolf-Peeters, and P. Marynen Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination Cancer Res. 66 2006 5270 5277
83. Z. Li, H. Wang, L. Xue, D.M. Shin, D. Roopenian, W. Xu, C.F. Qi, M.Y. Sangster, C.J. Orihuela, E. Tuomanen, J.E. Rehg, X. Cui, Q. Zhang, H.C. Morse 3rd, and S.W. Morris Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma Blood 114 2009 4158 4168
84. C. Vicente-Dueñas, L. Fontan, I. Gonzalez-Herrero, I. Romero-Camarero, V. Segura, M.A. Aznar, E. Alonso-Escudero, E. Campos-Sanchez, L. Ruiz-Roca, M. Barajas-Diego, A. Sagardoy, J.I. Martinez-Ferrandis, F. Abollo-Jimenez, C. Bertolo, I. Penuelas, F.J. Garcia-Criado, M.B. Garcia-Cenador, T. Tousseyn, X. Agirre, F. Prosper, F. Garcia-Bragado, E.D. McPhail, I.S. Lossos, M.Q. Du, T. Flores, J.M. Hernandez-Rivas, M. Gonzalez, A. Salar, B. Bellosillo, E. Conde, R. Siebert, X. Sagaert, C. Cobaleda, I. Sanchez-Garcia, and J.A. Martinez-Climent Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice Proc. Natl. Acad. Sci. U. S. A. 109 2012 10534 10539
85. L. Fontan, C. Yang, V. Kabaleeswaran, L. Volpon, M.J. Osborne, E. Beltran, M. Garcia, L. Cerchietti, R. Shaknovich, S.N. Yang, F. Fang, R.D. Gascoyne, J.A. Martinez-Climent, J.F. Glickman, K. Borden, H. Wu, and A. Melnick MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo Cancer Cell 22 2012 812 824
86. D. Nagel, S. Spranger, M. Vincendeau, M. Grau, S. Raffegerst, B. Kloo, D. Hlahla, M. Neuenschwander, J. Peter von Kries, K. Hadian, B. Dorken, P. Lenz, G. Lenz, D.J. Schendel, and D. Krappmann Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL Cancer Cell 22 2012 825 837
87. F. Schlauderer, K. Lammens, D. Nagel, M. Vincendeau, A.C. Eitelhuber, S.H. Verhelst, D. Kling, A. Chrusciel, J. Ruland, D. Krappmann, and K.P. Hopfner Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase Angew. Chem. 52 2013 10384 10387
88. C. Mc Guire, L. Elton, P. Wieghofer, J. Staal, S. Voet, A. Demeyer, D. Nagel, D. Krappmann, M. Prinz, R. Beyaert, and G. van Loo Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis J. Neuroinflammation 11 2014 124
89. M. Jaworski, B.J. Marsland, J. Gehrig, W. Held, S. Favre, S.A. Luther, M. Perroud, D. Golshayan, O. Gaide, and M. Thome Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity EMBO J. 33 2014 2765 2781
90. A. Gewies, O. Gorka, H. Bergmann, K. Pechloff, F. Petermann, K.M. Jeltsch, M. Rudelius, M. Kriegsmann, W. Weichert, M. Horsch, J. Beckers, W. Wurst, M. Heikenwalder, T. Korn, V. Heissmeyer, and J. Ruland Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation Cell Rep. 9 2014 1292 1305
91. F. Bornancin, F. Renner, R. Touil, H. Sic, Y. Kolb, I. Touil-Allaoui, J.S. Rush, P.A. Smith, M. Bigaud, U. Junker-Walker, C. Burkhart, J. Dawson, S. Niwa, A. Katopodis, B. Nuesslein-Hildesheim, G. Weckbecker, G. Zenke, B. Kinzel, E. Traggiai, D. Brenner, A. Brustle, M. St Paul, N. Zamurovic, K.D. McCoy, A. Rolink, C.H. Regnier, T.W. Mak, P.S. Ohashi, D.D. Patel, and T. Calzascia Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation J. Immunol. 194 2015 3723 3734
92. J.W. Yu, S. Hoffman, A.M. Beal, A. Dykon, M.A. Ringenberg, A.C. Hughes, L. Dare, A.D. Anderson, J. Finger, V. Kasparcova, D. Rickard, S.B. Berger, J. Ramanjulu, J.G. Emery, P.J. Gough, J. Bertin, and K.P. Foley MALT1 protease activity is required for innate and adaptive immune responses PLoS One 10 2015 e0127083
93. L. Shi, S. Chen, Y. Lu, X. Wang, L. Xu, F. Zhang, L. Yang, X. Wu, B. Li, and Y. Li Changes in the MALT1-A20-NF-kappaB expression pattern may be related to T cell dysfunction in AML Cancer Cell Int. 13 2013 37
94. M. Arora, D. Kaul, N. Varma, and R.K. Marwaha Cellular proteolytic modification of tumor-suppressor CYLD is critical for the initiation of human T-cell acute lymphoblastic leukemia Blood Cells Mol. Dis. 54 2015 132 138
95. H.H. Jabara, T. Ohsumi, J. Chou, M.J. Massaad, H. Benson, A. Megarbane, E. Chouery, R. Mikhael, O. Gorka, A. Gewies, P. Portales, T. Nakayama, H. Hosokawa, P. Revy, H. Herrod, F. Le Deist, G. Lefranc, J. Ruland, and R.S. Geha A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency J. Allergy Clin. Immunol. 132 2013 151 158
96. M.L. McKinnon, J. Rozmus, S.Y. Fung, A.F. Hirschfeld, K.L. Del Bel, L. Thomas, N. Marr, S.D. Martin, A.K. Marwaha, J.J. Priatel, R. Tan, C. Senger, A. Tsang, J. Prendiville, A.K. Junker, M. Seear, K.R. Schultz, L.M. Sly, R.A. Holt, M.S. Patel, J.M. Friedman, and S.E. Turvey Combined immunodeficiency associated with homozygous MALT1 mutations J. Allergy Clin. Immunol. 133 2014 1458-1462, 1462 e1451-1457
97. D. Punwani, H. Wang, A.Y. Chan, M.J. Cowan, J. Mallott, U. Sunderam, M. Mollenauer, R. Srinivasan, S.E. Brenner, A. Mulder, F.H. Claas, A. Weiss, and J.M. Puck Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation J. Clin. Immunol. 35 2015 135 146
98. P. Stepensky, B. Keller, M. Buchta, A.K. Kienzler, O. Elpeleg, R. Somech, S. Cohen, I. Shachar, L.A. Miosge, M. Schlesier, I. Fuchs, A. Enders, H. Eibel, B. Grimbacher, and K. Warnatz Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects J. Allergy Clin. Immunol. 131 2013 477-485 e471
99. J. Greil, T. Rausch, T. Giese, O.R. Bandapalli, V. Daniel, I. Bekeredjian-Ding, A.M. Stutz, C. Drees, S. Roth, J. Ruland, J.O. Korbel, and A.E. Kulozik Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency J. Allergy Clin. Immunol. 131 2013 1376-1383 e1373
100. S. Rosebeck, L. Madden, X. Jin, S. Gu, I.J. Apel, A. Appert, R.A. Hamoudi, H. Noels, X. Sagaert, P. Van Loo, M. Baens, M.Q. Du, P.C. Lucas, and L.M. McAllister-Lucas Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation Science 331 2011 468 472
101. J. Staal, Y. Driege, T. Bekaert, A. Demeyer, D. Muyllaert, P. Van Damme, K. Gevaert, and R. Beyaert T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1 EMBO J. 30 2011 1742 1752
102. M.A. 'O'Donnell, E. Perez-Jimenez, A. Oberst, A. Ng, R. Massoumi, R. Xavier, D.R. Green, and A.T. Ting Caspase 8 inhibits programmed necrosis by processing CYLD Nat. Cell Biol. 13 2011 1437 1442
103. I.E. Wertz, K.M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D.L. Boone, A. Ma, E.V. Koonin, and V.M. Dixit De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling Nature 430 2004 694 699
104. S. Hailfinger, H. Nogai, C. Pelzer, M. Jaworski, K. Cabalzar, J.E. Charton, M. Guzzardi, C. Decaillet, M. Grau, B. Dorken, P. Lenz, G. Lenz, and M. Thome Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines Proc. Natl. Acad. Sci. U. S. A. 108 2011 14596 14601
105. S.M. Ruben, J.F. Klement, T.A. Coleman, M. Maher, C.H. Chen, and C.A. Rosen I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity Genes Dev. 6 1992 745 760
106. T. Uehata, H. Iwasaki, A. Vandenbon, K. Matsushita, E. Hernandez-Cuellar, K. Kuniyoshi, T. Satoh, T. Mino, Y. Suzuki, D.M. Standley, T. Tsujimura, H. Rakugi, Y. Isaka, O. Takeuchi, and S. Akira Malt1-induced cleavage of regnase-1 in CD4 helper T cells regulates immune activation Cell 153 2013 1036 1049
107. K.M. Jeltsch, D. Hu, S. Brenner, J. Zoller, G.A. Heinz, D. Nagel, K.U. Vogel, N. Rehage, S.C. Warth, S.L. Edelmann, R. Gloury, N. Martin, C. Lohs, M. Lech, J.E. Stehklein, A. Geerlof, E. Kremmer, A. Weber, H.J. Anders, I. Schmitz, M. Schmidt-Supprian, M. Fu, H. Holtmann, D. Krappmann, J. Ruland, A. Kallies, M. Heikenwalder, and V. Heissmeyer Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation Nat. Immunol. 15 2014 1079 1089
108. M. Baens, L. Bonsignore, R. Somers, C. Vanderheydt, S.D. Weeks, J. Gunnarsson, E. Nilsson, R.G. Roth, M. Thome, and P. Marynen MALT1 auto-proteolysis is essential for NF-kappaB-dependent gene transcription in activated lymphocytes PLoS One 9 2014 e103774
109. Z. Nie, M.Q. Du, L.M. McAllister-Lucas, P.C. Lucas, N.G. Bailey, C.M. Hogaboam, M.S. Lim, and K.S. Elenitoba-Johnson Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma Nat. Commun. 6 2015 5908
110. C. Pop, P. Fitzgerald, D.R. Green, and G.S. Salvesen Role of proteolysis in caspase-8 activation and stabilization Biochemistry 46 2007 4398 4407
111. A.C. Eitelhuber, O. Vosyka, D. Nagel, M. Bognar, D. Lenze, K. Lammens, F. Schlauderer, D. Hlahla, K.P. Hopfner, G. Lenz, M. Hummel, S.H. Verhelst, and D. Krappmann Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas Chem. Biol. 22 2015 129 138
112. J. Hachmann, L.E. Edgington-Mitchell, M. Poreba, L.E. Sanman, M. Drag, M. Bogyo, and G.S. Salvesen Probes to monitor activity of the paracaspase MALT1 Chem. Biol. 22 2015 139 147
113. B.F. Cravatt, A.T. Wright, and J.W. Kozarich Activity-based protein profiling: from enzyme chemistry to proteomic chemistry Annu. Rev. Biochem. 77 2008 383 414
114. L.E. Edgington, M. Verdoes, and M. Bogyo Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes Curr. Opin. Chem. Biol. 15 2011 798 805
115. C. Pelzer, K. Cabalzar, A. Wolf, M. Gonzalez, G. Lenz, and M. Thome The protease activity of the paracaspase MALT1 is controlled by monoubiquitination Nat. Immunol. 14 2013 337 345